Standard
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine : An EPICOVIDEHA Report. / Salmanton-García, Jon; Marchesi, Francesco; Glenthøj, Andreas; Bilgin, Yavuz M.; Van Praet, Jens; Dávila-Valls, Julio; Martín-Pérez, Sonia; Labrador, Jorge; Van Doesum, Jaap; Falces-Romero, Iker; Farina, Francesca; Schönlein, Martin; Chanut, Mathilde; Petzer, Verena; Espigado, Ildefonso; Dargenio, Michelina; Aujayeb, Avinash; Sili, Uluhan; Serrano, Laura; Pinczés, László Imre; De Jonge, Nick; Soto-Silva, Andrés; Buquicchio, Caterina; Prezioso, Lucia; Marchetti, Monia; Meers, Stef; Busca, Alessandro; Corradini, Paolo; Hoenigl, Martin; Koehler, Philipp; Rahimli, Laman; Çolak, Gökçe Melis; Arellano, Elena; Wolf, Dominik; Gräfe, Stefanie; Ammatuna, Emanuele; Berg Venemyr, Caroline; Cornely, Oliver A.; Pagano, Livio.
I:
HemaSphere, Bind 6, Nr. 11, 2022, s. E789.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Salmanton-García, J, Marchesi, F
, Glenthøj, A, Bilgin, YM, Van Praet, J, Dávila-Valls, J, Martín-Pérez, S, Labrador, J, Van Doesum, J, Falces-Romero, I, Farina, F, Schönlein, M, Chanut, M, Petzer, V, Espigado, I, Dargenio, M, Aujayeb, A, Sili, U, Serrano, L, Pinczés, LI, De Jonge, N, Soto-Silva, A, Buquicchio, C, Prezioso, L, Marchetti, M, Meers, S, Busca, A, Corradini, P, Hoenigl, M, Koehler, P, Rahimli, L, Çolak, GM, Arellano, E, Wolf, D, Gräfe, S, Ammatuna, E, Berg Venemyr, C, Cornely, OA & Pagano, L 2022, '
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report',
HemaSphere, bind 6, nr. 11, s. E789.
https://doi.org/10.1097/HS9.0000000000000789APA
Salmanton-García, J., Marchesi, F.
, Glenthøj, A., Bilgin, Y. M., Van Praet, J., Dávila-Valls, J., Martín-Pérez, S., Labrador, J., Van Doesum, J., Falces-Romero, I., Farina, F., Schönlein, M., Chanut, M., Petzer, V., Espigado, I., Dargenio, M., Aujayeb, A., Sili, U., Serrano, L., ... Pagano, L. (2022).
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report.
HemaSphere,
6(11), E789.
https://doi.org/10.1097/HS9.0000000000000789Vancouver
Salmanton-García J, Marchesi F
, Glenthøj A, Bilgin YM, Van Praet J, Dávila-Valls J o.a.
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report.
HemaSphere. 2022;6(11):E789.
https://doi.org/10.1097/HS9.0000000000000789Author
Salmanton-García, Jon ; Marchesi, Francesco ; Glenthøj, Andreas ; Bilgin, Yavuz M. ; Van Praet, Jens ; Dávila-Valls, Julio ; Martín-Pérez, Sonia ; Labrador, Jorge ; Van Doesum, Jaap ; Falces-Romero, Iker ; Farina, Francesca ; Schönlein, Martin ; Chanut, Mathilde ; Petzer, Verena ; Espigado, Ildefonso ; Dargenio, Michelina ; Aujayeb, Avinash ; Sili, Uluhan ; Serrano, Laura ; Pinczés, László Imre ; De Jonge, Nick ; Soto-Silva, Andrés ; Buquicchio, Caterina ; Prezioso, Lucia ; Marchetti, Monia ; Meers, Stef ; Busca, Alessandro ; Corradini, Paolo ; Hoenigl, Martin ; Koehler, Philipp ; Rahimli, Laman ; Çolak, Gökçe Melis ; Arellano, Elena ; Wolf, Dominik ; Gräfe, Stefanie ; Ammatuna, Emanuele ; Berg Venemyr, Caroline ; Cornely, Oliver A. ; Pagano, Livio. / Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine : An EPICOVIDEHA Report. I: HemaSphere. 2022 ; Bind 6, Nr. 11. s. E789.
Bibtex
@article{9159e7321f1c4f6a898cf4c13dcd2ba3,
title = "Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report",
author = "Jon Salmanton-Garc{\'i}a and Francesco Marchesi and Andreas Glenth{\o}j and Bilgin, {Yavuz M.} and {Van Praet}, Jens and Julio D{\'a}vila-Valls and Sonia Mart{\'i}n-P{\'e}rez and Jorge Labrador and {Van Doesum}, Jaap and Iker Falces-Romero and Francesca Farina and Martin Sch{\"o}nlein and Mathilde Chanut and Verena Petzer and Ildefonso Espigado and Michelina Dargenio and Avinash Aujayeb and Uluhan Sili and Laura Serrano and Pincz{\'e}s, {L{\'a}szl{\'o} Imre} and {De Jonge}, Nick and Andr{\'e}s Soto-Silva and Caterina Buquicchio and Lucia Prezioso and Monia Marchetti and Stef Meers and Alessandro Busca and Paolo Corradini and Martin Hoenigl and Philipp Koehler and Laman Rahimli and {\c C}olak, {G{\"o}k{\c c}e Melis} and Elena Arellano and Dominik Wolf and Stefanie Gr{\"a}fe and Emanuele Ammatuna and {Berg Venemyr}, Caroline and Cornely, {Oliver A.} and Livio Pagano",
note = "Funding Information: EPICOVIDEHA has received funds from Optics COMMITTM (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States (Project 2020-8223). The funder of the study had no role in study design, data analysis, interpretation, or writing of the report. All authors had full access to the data and had final responsibility for the decision to submit for publication.",
year = "2022",
doi = "10.1097/HS9.0000000000000789",
language = "English",
volume = "6",
pages = "E789",
journal = "HemaSphere",
issn = "2572-9241",
publisher = "Lippincott, Williams & Wilkins",
number = "11",
}
RIS
TY - JOUR
T1 - Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine
T2 - An EPICOVIDEHA Report
AU - Salmanton-García, Jon
AU - Marchesi, Francesco
AU - Glenthøj, Andreas
AU - Bilgin, Yavuz M.
AU - Van Praet, Jens
AU - Dávila-Valls, Julio
AU - Martín-Pérez, Sonia
AU - Labrador, Jorge
AU - Van Doesum, Jaap
AU - Falces-Romero, Iker
AU - Farina, Francesca
AU - Schönlein, Martin
AU - Chanut, Mathilde
AU - Petzer, Verena
AU - Espigado, Ildefonso
AU - Dargenio, Michelina
AU - Aujayeb, Avinash
AU - Sili, Uluhan
AU - Serrano, Laura
AU - Pinczés, László Imre
AU - De Jonge, Nick
AU - Soto-Silva, Andrés
AU - Buquicchio, Caterina
AU - Prezioso, Lucia
AU - Marchetti, Monia
AU - Meers, Stef
AU - Busca, Alessandro
AU - Corradini, Paolo
AU - Hoenigl, Martin
AU - Koehler, Philipp
AU - Rahimli, Laman
AU - Çolak, Gökçe Melis
AU - Arellano, Elena
AU - Wolf, Dominik
AU - Gräfe, Stefanie
AU - Ammatuna, Emanuele
AU - Berg Venemyr, Caroline
AU - Cornely, Oliver A.
AU - Pagano, Livio
N1 - Funding Information:
EPICOVIDEHA has received funds from Optics COMMITTM (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States (Project 2020-8223). The funder of the study had no role in study design, data analysis, interpretation, or writing of the report. All authors had full access to the data and had final responsibility for the decision to submit for publication.
PY - 2022
Y1 - 2022
U2 - 10.1097/HS9.0000000000000789
DO - 10.1097/HS9.0000000000000789
M3 - Letter
C2 - 36310756
AN - SCOPUS:85143836045
VL - 6
SP - E789
JO - HemaSphere
JF - HemaSphere
SN - 2572-9241
IS - 11
ER -
